---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-017071"
form_type: "8-K"
ticker: null
cik: "0001008586"
company_name: "STREAMLINE HEALTH SOLUTIONS INC."
filed_at: "2024-04-29T23:59:59+00:00"
generated_at: "2026-06-03T05:19:31.167686+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Streamline Health Q4 rev $5.4M, net loss improves; Nasdaq extends bid price compliance to Oct 2024

## Summary
- Q4 FY2023 revenue $5.4M (down 19% YoY); net loss ($1.4M) vs ($2.2M) prior year; adjusted EBITDA $0.4M vs ($0.2M).
- Full-year FY2023 revenue $22.6M (down 9% YoY); net loss ($18.7M) including $10.8M impairment; adjusted EBITDA loss improved to ($1.4M) from ($3.8M).
- SaaS revenue grew $1.7M YoY; booked SaaS ACV $15.6M as of April 29, 2024, above adjusted EBITDA breakeven run rate of $15.5M.
- Nasdaq granted additional 180-day period until Oct 21, 2024 to regain minimum bid price of $1.00 per share.
- Bryant J. Reeves III appointed permanent CFO effective April 29, 2024; base salary increased to $225K; CEO Stilwill salary increased to $375K; both granted restricted stock.

## SEC filing metadata
- accession: 0001493152-24-017071
- form_type: 8-K
- cik: 0001008586
- company_name: STREAMLINE HEALTH SOLUTIONS INC.
- filed_at: 2024-04-29T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 3.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1008586/000149315224017071/0001493152-24-017071-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1008586/000149315224017071/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-017071
- JSON: https://secwatch.observer/filing/0001493152-24-017071.json
- Plain text: https://secwatch.observer/filing/0001493152-24-017071.txt

## Key facts
- Earnings Releases
  STREAMLINE HEALTH SOLUTIONS INC. reported the twelve months ended January 31, 2024 results: revenue $22.6 million, net income ($18.7 million). Guidance reaffirmed.
  - Period: the twelve months ended January 31, 2024
  - Revenue: $22.6 million
  - Net income: ($18.7 million)
  - Guidance: reaffirmed
  - Result: reported results
  source text: For the twelve months ended January 31, 2024, revenue totaled $22.6 million as compared to $24.9 million during fiscal 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1008586/000149315224017071/0001493152-24-017071-index.htm
- Earnings Releases
  STREAMLINE HEALTH SOLUTIONS INC. reported the fourth quarter of fiscal 2023 results: revenue $5.4 million, net income ($1.4 million). Guidance reaffirmed.
  - Period: the fourth quarter of fiscal 2023
  - Revenue: $5.4 million
  - Net income: ($1.4 million)
  - Guidance: reaffirmed
  - Result: reported results
  source text: Total revenue for the fourth quarter of fiscal 2023 was $5.4 million as compared to $6.7 million during the fourth quarter of fiscal 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1008586/000149315224017071/0001493152-24-017071-index.htm
- Listing & Compliance Notices
  STREAMLINE HEALTH SOLUTIONS INC. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: compliance regained
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: April 22, 2024, to regain compliance with the Minimum Bid Price Requirement. On April 23, 2024, the Company received a letter from the Staff informing the Company that, while the Company has not regained compliance with the Minimum Bid Price Requirement, the Staff has determined that the Company is eligible for an additional 180 calendar day period, or until October 21, 2024 (the “Second Compliance Period”), to regain compliance. If at any time during the Second Compliance Period, the closing bid price of the Common Stock is at least $1.00 per share for a minimum of 10 consecutive business day
  evidence_url: https://www.sec.gov/Archives/edgar/data/1008586/000149315224017071/0001493152-24-017071-index.htm
- Executive change
  Bryant J. Reeves, III was appointed as Chief Financial Officer at STREAMLINE HEALTH SOLUTIONS INC..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On April 29, 2024, the Company appointed Bryant J. Reeves, III as the Company’s permanent Chief Financial Officer, effective April 29, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1008586/000149315224017071/0001493152-24-017071-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.